Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.
about
A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGDEffectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer.Valproic acid induces Notch1 signaling in small cell lung cancer cellsEndobronchial cryobiopsy or forceps biopsy for lung cancer diagnosis.Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancerCyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer.Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer.Lung cancer incidence in erzurum city.Stereological Evaluation of Tumor Regression Rates in Lung Cancer Using CT Via the Cavalieri Method.Chronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2002.Up-regulation of ALG-2 in hepatomas and lung cancer tissue.EGFR mutation: Significance as a stratification factor in the era of molecular-targeted therapyLimited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology.Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis.Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.Small cell lung cancer: treatment review.Chemotherapy for patients with advanced lung cancer receiving long-term oxygen therapy.Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.Staging and diagnosis of non-small cell lung cancer: invasive modalities.Adjuvant chemotherapy in resected lung cancer: two-year experience in a university hospital.Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage I and II Nonsmall Cell Lung Cancer.Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility?Intratumoural chemotherapy of lung cancer for diagnosis and treatment of draining lymph node metastasis.Current clinical applications of endobronchial ultrasound.Current status of circulating protein biomarkers to aid the early detection of lung cancer.Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunitiesOrganosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity.Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.Ethnic disparities in the treatment of stage I non-small cell lung cancer.Tandem mass spectrometry-based newborn screening strategy could be used to facilitate rapid and sensitive lung cancer diagnosis.Imaging of recurrent lung cancer.Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer.Alveolar macrophage function is altered in patients with lung cancer.Interstitial lung disease in patients with non-small-cell lung cancer: causes, mechanisms and management.Moving away from PPARs - EGFR signaling and the anti-cancer effects of thiazolinedinediones.The investigation of ceranib-2 on apoptosis and drug interaction with carboplatin in human non small cell lung cancer cells in vitro.Predictors of quality-of-life improvement following pulmonary resection due to lung cancer.Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.The clinical importance of bone metabolic markers in detecting bone metastasis of lung cancer.Experimental model of pulmonary carcinogenesis in Wistar rats.
P2860
Q28548244-1AD66957-5549-4BBE-BC42-6E1CCA005F6FQ33635117-53A73602-8BD4-4551-B684-E70C27D595E8Q33976203-FDBD6200-7166-4887-9B27-370E07712E4DQ34195965-6CD2FC03-55F6-4A4D-BD80-1256810F4800Q34198721-78A9BF42-A238-4449-82CF-EBA2F7AD8D07Q34346323-F76F695D-906B-45A8-8378-E0552DBC0348Q34490262-FBEE3F4D-FC75-40DE-B408-114E7A26E8B7Q34665886-B5E2A72D-58DC-4689-BCA9-53BCB1309EDBQ34667988-78681A9B-7166-410E-8996-19D14A30590AQ35055460-9C6CFC25-D186-40EB-9C36-B322BB5E623DQ35791541-EFD6B119-EC19-4852-A8BB-9625FD4EC1B5Q36135844-BC00F5F4-EF35-4E04-BBB0-A7F24AD6FC9AQ36162516-7D7CC553-4B67-4BB4-9895-114DCE2403F5Q36182455-82011C31-4502-4265-B556-08F6E89186BAQ36273955-8BDE73E6-1A74-403D-A295-C1F51C69A82AQ36458604-1430E85C-F8B1-467D-BD05-361663E85B07Q36540329-9A32132C-3852-4108-9813-93E24BE06AB4Q36612331-9CA0F6F1-5C30-4E93-BBF8-1ED1EFCDFAB5Q36735015-E29E9D43-F1F6-49B4-8777-385EC7AD9211Q37185492-B7CD0257-0B43-4414-9B9D-BE5BB33006A2Q37228469-75F304C0-C8D3-4717-A222-55DAA47DEC50Q37480860-C55780BE-F65C-4655-A470-7D83AFAB8E99Q37757142-FA3EFF09-F555-416D-9318-DA3B8470D24EQ37775626-9C53E972-0F88-41A6-BBC5-6659B26A21E0Q38232856-7EBD9812-D552-4048-B2E8-73417E0ECB3AQ39306543-DE688AC9-F9F0-4D18-B205-627067B677EFQ39418780-8E763B08-363E-408E-AE6B-01FEC32F38FAQ40078667-0398FFF9-84E3-4CE4-95B2-D27ACF52FBC1Q40442413-C916D8B5-76BF-4CBE-BDAD-5718BF53CF94Q40878024-56E87982-2F9F-40DB-85DA-659BB5C8736FQ41818072-F3FDA8A6-53E4-4496-9C92-EEA310E3E13BQ41900593-1CC5CF76-19D1-4309-9FDB-1237E318804EQ42164579-40F36DFB-728A-432A-8692-A8FCD054A4DFQ42278411-E384ED90-BC12-4DFA-BBA8-ECA81DB8D8BFQ45986928-0419078D-89BF-4419-9D26-953402224C79Q49913969-01C7D4B0-086C-4234-B8B3-71A47A4C6227Q50900615-36D36F0E-C696-4C1F-865F-BFAF0597F617Q52110012-E9FF1F74-0A06-4E94-8163-B004ABDD0C4AQ53218162-907E8F94-18F0-42C5-9899-97618648A4CAQ53333360-36BDDF77-A7BD-463D-BE52-5E76C38B885A
P2860
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.
@ast
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.
@en
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.
@nl
type
label
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.
@ast
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.
@en
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.
@nl
prefLabel
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.
@ast
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.
@en
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.
@nl
P2860
P1476
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment
@en
P2093
Stephen G Spiro
P2860
P304
P356
10.1164/RCCM.200202-070SO
P407
P577
2002-11-01T00:00:00Z